{"id":451249,"date":"2021-03-04T16:08:25","date_gmt":"2021-03-04T21:08:25","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=451249"},"modified":"2021-03-04T16:08:25","modified_gmt":"2021-03-04T21:08:25","slug":"diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/","title":{"rendered":"Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CHARLOTTESVILLE, Va., March  04, 2021  (GLOBE NEWSWIRE) &#8212; <strong>Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN)<\/strong>\u00a0(\u201cDiffusion\u201d or the \u201cCompany\u201d), an innovative biopharmaceutical company developing novel therapies that enhance the body\u2019s ability to deliver oxygen to areas where it is needed most, announced today that Robert J. Cobuzzi, Ph.D., CEO of Diffusion, will\u00a0present at\u00a0the H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021.\u00a0The presentation will be available on demand during the virtual event for all registered attendees.\u00a0<\/p>\n<p>Event details are as follows:\u00a0<\/p>\n<table style=\"border-collapse: collapse;width:70%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: bottom\">\n            <strong>Event:<\/strong>\u00a0<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: bottom\">\n            <strong>H.C. Wainwright Global Life Sciences Conference<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: bottom\">\n            <strong>Date:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: bottom\">Tuesday, March 9, 2021 to Wednesday, March 10, 2021\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">\n            <strong>Time:<\/strong><br \/>\n            <br \/>\n            <strong>Registration:<\/strong>\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: bottom\">Available on Demand\u00a0<br \/><a href=\"https:\/\/hcwevents.com\/globalconference\/\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/hcwevents.com\/globalconference\/<\/a><\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">During\u00a0the\u00a0presentation, Dr. Cobuzzi will\u00a0provide an overview of\u00a0Diffusion\u2019s recent corporate achievements, planned clinical trials, as well as potential milestones. Our presentation will be available\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HQ4Uyweh6LgFFoWRYX14kDwo9denIAIjZO-bfd3RwtnJ8ZakbIStwD9kc3o9EnbAIpGmdcxSPe9aH3fN-Qnv-V437IRyl5e7Rz9YffPxAV5dJu-M9uXdqkSxs5fpI0m-\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">here<\/a>, on the Investor Relations section of our website following the conference.<\/p>\n<p>\n        <strong>About Diffusion Pharmaceuticals Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body\u2019s ability to deliver oxygen to areas where it is needed most. Diffusion\u2019s lead product candidate, trans sodium crocetinate\u00a0(TSC), is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia, a serious complication of many of medicine\u2019s most intractable and difficult-to-treat conditions. In addition to TSC, Diffusion\u2019s product candidate DFN-529, a novel, allosteric PI3K\/Akt\/mTOR Pathway inhibitor, is in early-stage development. For more information, please visit us at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qcr4i1FEpLzm7STPVuIHnKz8TrSfoslyOCWB40jCXl5jYspic3YZwjHXlWFwxp4jKyimtlHT6ZQsuPiWjQ6yPBo1IVT6SfrFtN3qtodJ3gg=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.diffusionpharma.com<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This press release includes express and implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including regarding the anticipated use of proceeds from the offering. The Company may, in some cases, use terms such as \u201cbelieves,\u201d \u201cestimates,\u201d \u201canticipates,\u201d \u201cexpects,\u201d \u201cplans,\u201d \u201cintends,\u201d \u201cmay,\u201d \u201ccould,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201capproximately,\u201d or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Although the Company believes that it has a reasonable basis for each forward-looking statement contained herein, forward-looking statements by their nature involve risks and uncertainties, known and unknown, many of which are beyond the Company\u2019s control, and as a result the Company\u2019s actual results could differ materially from those expressed or implied in any forward-looking statement. Particular risk and uncertainties include, among other things, those related to: the Company\u2019s ability to design, initiate, execute, and complete its ongoing and planned studies evaluating TSC;; the Company\u2019s ability to develop and commercialize TSC or any other product candidate; general economic, political, business, industry, and market conditions, including the ongoing COVID-19 pandemic; and the other factors discussed under the heading \u201cRisk Factors\u201d in the Company\u2019s filings with the U.S. Securities and Exchange Commission (\u201cSEC\u201d). Any forward-looking statements in this press release speak only as of the date hereof (or such earlier date as may be identified) and, except as required by applicable law, rule, or regulation, the Company undertakes no obligation to update any such statements after the date hereof.<\/p>\n<p>\n        <strong>Contacts<\/strong><br \/>\n        <br \/>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F6hJuz_MqxhHg9_IiRtBfAyyCVCMRyeXTjh2UCE8qq0iGBqwpZfSpPnBmIdymJ5_vxTqViMp8roc4DKy6MVdJ-JkbNnKy3MLQbOrmAc7lm0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Tiberend Strategic Advisors, Inc.<\/a>\u00a0<br \/>Maureen McEnroe, CFA\/Miriam Weber Miller\u00a0<br \/>(212)\u00a0375-2664 \/ (212) 375-2694<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=b1L0VcRXS0QYSUMfmlaB672hymvPV1TCD2Msqq_CBsDXhXN9nZVr8Jrqd1jVi7pg1yMDrgmn0ltuvboln4vqVmlrqjMUADvmRHBUJKuvA1k=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mmcenroe@tiberend.com<\/a>\u00a0\/\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cEhyUzoPSJAtqGKBVDNd0IKpHJzNRzr05fhXB-V0Yqavwtv1RAh3QScdzgmU49mqjCLR_Jm6HLrzCI00yAO5osf2C_1G0vnEKO2lFc36D3A=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mmiller@tiberend.com<\/a><\/p>\n<p>\n        <strong>Media:<\/strong><br \/>\n        <br \/>Jeffrey Freedman<br \/>RooneyPartners<br \/>(646) 432-0191\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pVsQhTj8x1YBbroFndh6a79kh9DGupvDTMZ1iIBWJtNvQagMTwz21ezyqZI2X4a4aUEVcm05lIiysf9lB76ZJRlpAe6L-eg7JUqT26HkoPU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">jfreedman@rooneyco.com<\/a><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDgzOCM0MDQ5NTM0IzIwMjg5NDM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/ac8a10cd-1c60-4600-bd6c-cb74403f328c\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHARLOTTESVILLE, Va., March 04, 2021 (GLOBE NEWSWIRE) &#8212; Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN)\u00a0(\u201cDiffusion\u201d or the \u201cCompany\u201d), an innovative biopharmaceutical company developing novel therapies that enhance the body\u2019s ability to deliver oxygen to areas where it is needed most, announced today that Robert J. Cobuzzi, Ph.D., CEO of Diffusion, will\u00a0present at\u00a0the H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021.\u00a0The presentation will be available on demand during the virtual event for all registered attendees.\u00a0 Event details are as follows:\u00a0 Event:\u00a0 H.C. Wainwright Global Life Sciences Conference Date: Tuesday, March 9, 2021 to Wednesday, March 10, 2021\u00a0 Time: Registration:\u00a0 Available on Demand\u00a0https:\/\/hcwevents.com\/globalconference\/ During\u00a0the\u00a0presentation, Dr. Cobuzzi will\u00a0provide an overview of\u00a0Diffusion\u2019s recent corporate achievements, planned clinical trials, as well as potential milestones. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-451249","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHARLOTTESVILLE, Va., March 04, 2021 (GLOBE NEWSWIRE) &#8212; Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN)\u00a0(\u201cDiffusion\u201d or the \u201cCompany\u201d), an innovative biopharmaceutical company developing novel therapies that enhance the body\u2019s ability to deliver oxygen to areas where it is needed most, announced today that Robert J. Cobuzzi, Ph.D., CEO of Diffusion, will\u00a0present at\u00a0the H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021.\u00a0The presentation will be available on demand during the virtual event for all registered attendees.\u00a0 Event details are as follows:\u00a0 Event:\u00a0 H.C. Wainwright Global Life Sciences Conference Date: Tuesday, March 9, 2021 to Wednesday, March 10, 2021\u00a0 Time: Registration:\u00a0 Available on Demand\u00a0https:\/\/hcwevents.com\/globalconference\/ During\u00a0the\u00a0presentation, Dr. Cobuzzi will\u00a0provide an overview of\u00a0Diffusion\u2019s recent corporate achievements, planned clinical trials, as well as potential milestones. &hellip; Continue reading &quot;Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-04T21:08:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDgzOCM0MDQ5NTM0IzIwMjg5NDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference\",\"datePublished\":\"2021-03-04T21:08:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\\\/\"},\"wordCount\":547,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDgzOCM0MDQ5NTM0IzIwMjg5NDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\\\/\",\"name\":\"Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDgzOCM0MDQ5NTM0IzIwMjg5NDM=\",\"datePublished\":\"2021-03-04T21:08:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDgzOCM0MDQ5NTM0IzIwMjg5NDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDgzOCM0MDQ5NTM0IzIwMjg5NDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/","og_locale":"en_US","og_type":"article","og_title":"Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference - Market Newsdesk","og_description":"CHARLOTTESVILLE, Va., March 04, 2021 (GLOBE NEWSWIRE) &#8212; Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN)\u00a0(\u201cDiffusion\u201d or the \u201cCompany\u201d), an innovative biopharmaceutical company developing novel therapies that enhance the body\u2019s ability to deliver oxygen to areas where it is needed most, announced today that Robert J. Cobuzzi, Ph.D., CEO of Diffusion, will\u00a0present at\u00a0the H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021.\u00a0The presentation will be available on demand during the virtual event for all registered attendees.\u00a0 Event details are as follows:\u00a0 Event:\u00a0 H.C. Wainwright Global Life Sciences Conference Date: Tuesday, March 9, 2021 to Wednesday, March 10, 2021\u00a0 Time: Registration:\u00a0 Available on Demand\u00a0https:\/\/hcwevents.com\/globalconference\/ During\u00a0the\u00a0presentation, Dr. Cobuzzi will\u00a0provide an overview of\u00a0Diffusion\u2019s recent corporate achievements, planned clinical trials, as well as potential milestones. &hellip; Continue reading \"Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-04T21:08:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDgzOCM0MDQ5NTM0IzIwMjg5NDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference","datePublished":"2021-03-04T21:08:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/"},"wordCount":547,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDgzOCM0MDQ5NTM0IzIwMjg5NDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/","name":"Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDgzOCM0MDQ5NTM0IzIwMjg5NDM=","datePublished":"2021-03-04T21:08:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDgzOCM0MDQ5NTM0IzIwMjg5NDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDgzOCM0MDQ5NTM0IzIwMjg5NDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/diffusion-pharmaceuticals-inc-to-present-at-the-h-c-wainwright-global-life-sciences-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Diffusion Pharmaceuticals, Inc. to\u00a0Present at the H.C. Wainwright Global Life Sciences Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=451249"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451249\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=451249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=451249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=451249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}